Want to see KRSA full AI Analyst Report?
Korsana Biosciences (KRSA) Stock Statistics & Valuation Metrics
Total Valuation
Korsana Biosciences has a market cap or net worth of $1.37B. The enterprise value is $2.28M.
- Market Cap
- $1.37B
- Enterprise Value
- $2.28M
Share Statistics
Korsana Biosciences has 45,541,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 45,541,360
- Owned by Insiders
- 2.29%
- Owned by Institutions
- <0.01%
Financial Efficiency
Korsana Biosciences’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -54.74%.
- Return on Equity (ROE)
- -0.39
- Return on Assets (ROA)
- -0.35
- Return on Invested Capital (ROIC)
- -54.74%
- Return on Capital Employed (ROCE)
- -0.55
- Revenue Per Employee
- 109.16K
- Profits Per Employee
- -185.68K
- Employee Count
- 19
- Asset Turnover
- 0.21
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Korsana Biosciences is -2.50. Korsana Biosciences’s PEG ratio is 0.03.
- PE Ratio
- -2.50
- PS Ratio
- 74.26
- PB Ratio
- 3.60
- Price to FCF
- -31.70
- Price to Operating Cash Flow
- -4.11
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, Korsana Biosciences had revenue of 2.07M and earned -3.53M in profits. Earnings per share was -7.63.
- Revenue
- 2.07M
- Gross Profit
- 2.07M
- Operating Income
- -4.97M
- Pretax Income
- -3.53M
- Net Income
- -3.53M
- EBITDA
- -3.53M
- Earnings Per Share (EPS)
- -7.63
Cash Flow
In the last 12 months, operating cash flow was -4.45M and capital expenditures 0, giving a free cash flow of -4.45M billion.
- Operating Cash Flow
- -4.45M
- Free Cash Flow
- -4.45M
- Free Cash Flow per Share
- -7.33
Dividends & Yields
Korsana Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.15%
- Earnings Yield
- -36.64%
Stock Price Statistics
- Beta
- 1.78
- 52-Week Price Change
- 124.26%
- 50-Day Moving Average
- 31.08
- 200-Day Moving Average
- 22.31
- Relative Strength Index (RSI)
- 45.63
- Average Volume (3m)
- 72.41K
Important Dates
Korsana Biosciences upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- May 01, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Korsana Biosciences as a current ratio of 5.15, with Debt / Equity ratio of 0.00%
- Current Ratio
- 5.15
- Quick Ratio
- 5.15
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.92
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Korsana Biosciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Korsana Biosciences EV to EBITDA ratio is -20.83, with an EV/FCF ratio of -31.39.
- EV to Sales
- 73.53
- EV to EBITDA
- -20.83
- EV to Free Cash Flow
- -31.39
- EV to Operating Cash Flow
- -31.39
Balance Sheet
Korsana Biosciences has $1.39M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.39M billion.
- Cash & Marketable Securities
- $1.39M
- Total Debt
- $0.00
- Net Cash
- $1.39M
- Net Cash Per Share
- $0.03
- Tangible Book Value Per Share
- $8.38
Margins
Gross margin is 61.58%, with operating margin of -359.16%, and net profit margin of -353.00%.
- Gross Margin
- 61.58%
- Operating Margin
- -359.16%
- Pretax Margin
- -353.00%
- Net Profit Margin
- -353.00%
- EBITDA Margin
- -353.00%
- EBIT Margin
- -353.00%
Analyst Forecast
The average price target for Korsana Biosciences is $53.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $53.00
- Price Target Upside
- 75.85% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- -12.60%
- EPS Growth Forecast
- -126.24%
Scores
- Smart Score
- 9
- AI Score
- 47